Oral Adverse Events Associated with Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in Renal Cell Carcinoma: A Structured Literature Review

BACKGROUND. Oral adverse events (OAEs) associated with multitargeted tyrosine kinase inhibitors (TKIs) and mammalian target of rapamycin inhibitors (mTORIs) are underestimated but frequent and novel presentations of mucosal manifestations. Because optimal antitumor activity requires maintaining the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Boers-Doets, Christine B., Epstein, Joel B., Raber-Durlacher, Judith E., Ouwerkerk, Jan, Logan, Richard M., Brakenhoff, Jan A., Lacouture, Mario E., Gelderblom, Hans
Formato: Artigo
Lenguaje:Inglês
Publicado: AlphaMed Press 2012
Materias:
Symptom Management and Supportive Care
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3267813/
https://ncbi.nlm.nih.gov/pubmed/22207567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0111
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares